Curanex Pharmaceuticals Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -35 | 15 | |
EBITDA | -3,148 | 1,177 | -934 |
EBIT | -3,183 | 1,143 | -949 |
Net Income | -3,150 | -3,073 | -954 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -954 | -857 | -9,187 |
Cash | 4,018 | 4,973 | 5,830 |
Basic Shares | 1,417 | 1,274 | 1,279 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $26 |
Gross Profit | 0 | 4 | ||
EBITDA | -4,216 | -290 | -17 | |
EBIT | -4,216 | -19 | -20 | |
Net Income | -4,225 | -361 | -19 | -20 |
Net Change In Cash | 0 | 0 | 0 | 26 |
Free Cash Flow | -10,484 | -555 | 3 | |
Cash | 4,973 | 148 | 74 | 2 |
Basic Shares | 1,274 | 1,387 | 2,100 | 2,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.03 |
2026-03-31 | -$0.11 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.04 |